Contact Us


    December 16, 2019

    Genomind Expands Collaboration to Provide Access to Genetics-Based Mental Health Test to Customers in All Pennsylvania ACME Markets

    Specially trained ACME pharmacists will identify and work with patients who may benefit from Genomind Professional PGx Express – the most comprehensive genetic testing service aimed at improving mental health treatments

    Continue Reading...
    December 9, 2019

    Genomind Joins Forces With Sharecare to Improve Mental Health Outcomes

    Genomind brings expertise in mental health education and pharmacogenomics services to Sharecare’s comprehensive digital health platform

    Continue Reading...
    November 7, 2019

    Genomind Bolsters Medicare Reimbursement Initiatives, Obtaining Z-Codes for Genomind Professional PGx Express

    Designation critical step for Medicare local coverage determinant under the Molecular Diagnostic Services (MolDX) program

    Continue Reading...
    October 1, 2019

    Genomind and DrChrono Expand Collaboration to Improve Mental Health Outcomes With Innovative Technology and Services

    Most comprehensive mental health genetic profile available integrates seamlessly into patients’ electronic medical record

    Continue Reading...
    September 16, 2019

    Researchers Present New Data on the Utility of Genomind's Mental Health Pharmacogenomic Testing at Upcoming Scientific Conferences

    Abstracts presented at this year’s Psych Congress and NEI Congress expand the increasing body of evidence supporting Genomind’s approach to integrating pharmacogenomics into mental health treatment

    Continue Reading...
    August 19, 2019

    Genomind Partners with NeuroFlow, Transforming Model of Care for Mental Health Patients

    Unique collaborative service combines innovative digital health platform and genetic testing to improve patient wellness and lower costs across the continuum of care for conditions including depression, anxiety, PTSD, and substance abuse

    Continue Reading...